Overview

The Effect of Montelukast in Patients With Chronic Cough and Bronchial Hyperreactivity

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose is to determine whether montelukast during 6 weeks has superior antitussive effects (measured with the LCQ) compared with placebo in patients with cough lasting > 8 weeks and enhanced bronchial hyperreactivity.
Phase:
Phase 4
Details
Lead Sponsor:
Isala
Treatments:
Montelukast